ADVERTISEMENT

Jordan Kadish

News

Magrolimab and Azacitidine Combination Treatment for Patients With Untreated High-Risk MDS

04/28/2023

Jordan Kadish ;

According to a phase 1b trial, magrolimab and azacitidine combination treatment yielded safe and effective results among patients with untreated high-risk myelodysplastic syndromes.

According to a phase 1b trial, magrolimab and azacitidine combination treatment yielded safe and effective results among patients with untreated high-risk myelodysplastic syndromes.

According to a phase 1b trial,...

04/28/2023

Oncology

News

Prognostic Value of PET Status for Patients With R/R Follicular Lymphoma Undergoing AutoSCT

07/31/2023

Jordan Kadish ;

Pre-autologous stem cell transplantation positron emission tomography status has strong prognostic value and may help to improve the risk stratification and selection of patients for autoSCT, according to a retrospective analysis.

Pre-autologous stem cell transplantation positron emission tomography status has strong prognostic value and may help to improve the risk stratification and selection of patients for autoSCT, according to a retrospective analysis.

Pre-autologous stem cell...

07/31/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

NP Institute

March 27 ⁠–⁠ March 30

See Full Calendar

Advertisement

Advertisement